These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Topical application of tranexamic acid for the reduction of bleeding. Ker K, Beecher D, Roberts I. Cochrane Database Syst Rev; 2013 Jul 23; (7):CD010562. PubMed ID: 23881695 [Abstract] [Full Text] [Related]
4. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Cochrane Database Syst Rev; 2011 Mar 16; 2011(3):CD001886. PubMed ID: 21412876 [Abstract] [Full Text] [Related]
5. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Cochrane Database Syst Rev; 2011 Jan 19; (1):CD001886. PubMed ID: 21249650 [Abstract] [Full Text] [Related]
6. Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer. Kietpeerakool C, Supoken A, Laopaiboon M, Lumbiganon P. Cochrane Database Syst Rev; 2016 Jan 23; 2016(1):CD011732. PubMed ID: 26801659 [Abstract] [Full Text] [Related]
12. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions. van Galen KP, Engelen ET, Mauser-Bunschoten EP, van Es RJ, Schutgens RE. Cochrane Database Syst Rev; 2015 Dec 24; (12):CD011385. PubMed ID: 26704192 [Abstract] [Full Text] [Related]